跳至主要内容
临床试验/NCT06672926
NCT06672926招募中不适用

NEWPROMRI-PATHWAY - A New Prostate Magnetic Resonance Imaging (MRI) Pathway

University Hospitals of North Midlands NHS Trust1 个研究点 分布在 1 个国家目标入组 1,600 人开始时间: 2025年9月23日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
1,600
试验地点
1
主要终点
Use of Gadolinium Based Contrast Agent (GBCA) injection

研究概览

简要总结

Prostate cancer is the second most common cancer in men worldwide. The demand for magnetic resonance imaging (MRI) to diagnose and manage prostate cancer is continually growing. There is, however, a severe global shortage of radiologists who review and make decisions on prostate scans. This shortage causes compromises that are inefficient and negatively affect care provision, patient outcomes, and patient experiences. Two key examples of these compromises are that every patient receives a gadolinium contrast injection during a prostate MRI scan and patients often require multiple imaging appointments. If radiologists' knowledge of making prostate MRI decisions around these compromises could be harnessed and passed to radiographers (who are trained to acquire the MRIs but currently do not review them) with a computerised system to support clinical decision-making, this would have enormous potential to improve the diagnosing and managing prostate cancer.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • MRI radiographers in University Hospitals of North Midlands (UHNM) and or University Hospitals of Derby and Burton (UHDB) with over 5 years' experience in MRI of the prostate.
  • Radiographers from UHNM or UHDB who have completed an online and hands on study specific training materials before the testing phase.
  • Retrospective data of 800 patients each from UHNM and UHDB who have had mpMRI and went on to have a biopsy.

排除标准

  • Non-MRI radiographers.
  • Radiographers who did not completed an online and hands on study specific training materials before the testing phase.
  • Non-mpMRI.

结局指标

主要结局

Use of Gadolinium Based Contrast Agent (GBCA) injection

时间窗: 12 months

Equivalence between radiographers and radiologists in deciding when Gadolinium Based Contrast Agent (GBCA) injection is required in prostate MRI scans. This is by comparing radiographers' diagnoses (decisions on whether GBCA injection would have been required) with radiologists' decisions to determine equivalence in prostate cancer diagnosis using prostate MRI.

Application of WB-MRI

时间窗: 12 months

Equivalence between radiographers and radiologists in deciding when WB-MRI is required in prostate MRI scans. This is by comparing radiographers' decisions (decisions on whether WB-MRI would have been required) with radiologists' decisions to determine equivalence in prostate cancer diagnosis using prostate MRI.

Radiographers opinions

时间窗: 12 months

The Decisional Conflict Scale (DCS) will be used to capture radiographers' opinions on how they felt about the tasks and support they are given during their preparation and afterward

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验